Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group.
Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Celano R, Civitelli F, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Panceri R, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M. Arrigo S, et al. Among authors: moretti c. Dig Liver Dis. 2021 Mar;53(3):283-288. doi: 10.1016/j.dld.2020.12.011. Epub 2020 Dec 26. Dig Liver Dis. 2021. PMID: 33388247 Free PMC article.
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.
Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Dilillo A, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M. Arrigo S, et al. Among authors: moretti c. Dig Liver Dis. 2021 Feb;53(2):183-189. doi: 10.1016/j.dld.2020.10.024. Epub 2020 Oct 22. Dig Liver Dis. 2021. PMID: 33132063 Free PMC article. Review.
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).
Maddaloni E, D'Onofrio L, Alessandri F, Mignogna C, Leto G, Pascarella G, Mezzaroma I, Lichtner M, Pozzilli P, Agrò FE, Rocco M, Pugliese F, Lenzi A, Holman RR, Mastroianni CM, Buzzetti R; CoViDiab Study Group. Maddaloni E, et al. Cardiovasc Diabetol. 2020 Oct 1;19(1):164. doi: 10.1186/s12933-020-01140-2. Cardiovasc Diabetol. 2020. PMID: 33004045 Free PMC article.
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study.
D'Onofrio L, Mignogna C, Carlone A, Bellizzi E, Di Guida M, Moretti C, Zampetti S, Leto G, Maddaloni E, Buzzetti R. D'Onofrio L, et al. Among authors: moretti c. Diabetes Res Clin Pract. 2021 Mar;173:108681. doi: 10.1016/j.diabres.2021.108681. Epub 2021 Jan 28. Diabetes Res Clin Pract. 2021. PMID: 33516784
693 results